Skip to main navigation Skip to search Skip to main content

Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs

  • Ana Luiza de Andrade Querino
  • , Alessandra Mara de Sousa
  • , Sophie R. Thomas
  • , Geraldo Magela de Lima
  • , Dalton Dittz
  • , Angela Casini
  • , Rubens Lima do Monte-Neto
  • , Heveline Silva
  • Universidade Federal de Minas Gerais
  • Technical University of Munich
  • Oswaldo Cruz Foundation
  • Federal University of Piauí

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

The limited chemical stability of gold(III)-based compounds in physiological environment has been a challenge in drug discovery, and organometallic chemistry might provide the solution to overcome this issue. In this work, four novel cationic organogold(III)-dithiocarbamate complexes of general structure [(C^N)AuIIIDTC]PF6 (C1a – C4a, DTC = dithiocarbamate, L1 – L4, C^N = 2-anilinopyridine) are presented, and compared to their coordination gold(III)-dithiocarbamate analogues [AuIIIDTCCl2] (C1b – C4b), as potential anti-cancer and anti-leishmanial drugs. Most of the complexes effectively inhibited cancer cell growth, notably C3a presented anti-proliferative effect in the nanomolar range against breast cancer (MCF-7 and MDA-MB-231 cells with moderate selectivity. Pro-apoptotic studies on treated MCF-7 cells showed a high population of cells in early apoptosis. Reactivity studies of C3a towards model thiols (N-acetyl-L-cysteine) refer to a possible mode of action involving bonding between the organogold(III)-core and the thiolate. In the scope of neglected diseases, gold complexes are emerging as promising therapeutic alternatives against leishmaniasis. In this regard, all gold(III)-dithiocarbamate complexes presented anti-leishmanial activity against at least one Leishmania species. Complexes C1a, C4a, C1b, C4b were active against all tested parasites with IC50 values varying between 0.12 and 42 μM, and, overall, organometallic compounds presented more intriguing inhibition profiles. For C4a selectivity over 500-fold for L. braziliensis; even higher than the reference anti-leishmanial drug amphotericin B. Overall, our findings revealed that the organogold(III) moiety significantly amplified the anti-cancer and anti-leishmanial effects with respect to the coordination analogues; thus, showing the great potential of organometallic chemistry in metallodrug-based chemotherapy for cancer and leishmaniasis.

Original languageEnglish
Article number112346
JournalJournal of Inorganic Biochemistry
Volume247
DOIs
StatePublished - Oct 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Amastigotes
  • Anticancer
  • Dithiocarbamate ligands
  • Gold complexes
  • Organometallic drugs

Fingerprint

Dive into the research topics of 'Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs'. Together they form a unique fingerprint.

Cite this